The GENETWORx COVID-19 Total Antibody (IgM & IgG) assay is a blood test that is performed to determine if someone has had an immune response to COVID-19.

The COVID-19 Antibody Test has a 99.8% specificity and 100% sensitivity and only checks to see if the immune system has responded to the infection.

If there are antibodies present in the blood, this is a sign that the individual has likely already had COVID-19. The COVID-19 Antibody Test is not for diagnosing an active COVID-19 infection; it is only for testing whether the immune system, the body’s defense against illness, has responded to the infection.

The presence of antibodies to SARS-CoV-2 indicates that the patient being tested, whether symptomatic or asymptomatic, has had an immune response to the virus. Total antibody tests detect both IgG and IgM in the blood to provide a clearer disease-state picture. These assays are more sensitive than the use of IgG or IgM alone for early detection of an immune response.

While the test is most accurate when performed at least 14 days after infection, if you don’t have symptoms but suspect you may have been infected, this test can be conducted at any point.

With one of the fastest results-reporting platforms in the world, results can be accessed in GENETWORx’s portal in less than 72 hours, as well as on the phone or by text.

Ready for a test?